Hide Board Information

Show Board Information

CEN BIOTECH INC.

Board Mod: FITXdawg

Asst Mods: SIObserver BigAddison Courtjester

Last Post: 07/30/2020 12:04:54 PM

Board Marks: 63

Posts Today: 0

Board Views Today: 184

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1247	http://www.cenmedicalgroup.com	BigAddison	09/26/2017 10:52:29 AM
1277	The new CEN Biotech Inc. website is now live and (2)	Courtjester	06/07/2018 4:41:48 PM
8	I guess I will bring up the	Chops123	12/08/2014 8:23:13 AM
7	Glad to be here; looking forward to a great	tonsco1	12/07/2014 2:19:22 PM
6	6 here	MAC770	12/04/2014 6:05:29 PM
5	did I get in 5th	OWLWHO	12/04/2014 6:01:39 PM
4	Can't wait... Good luck.	withlove	12/03/2014 2:22:55 PM
3	3rd! CEN BIOTECH is Coming!!	FITXdawg	11/30/2014 9:32:16 AM
2	Hello 2nd post lol	Mariah The Wind	11/30/2014 9:29:00 AM
1	THIS IS THE FIRST POST!!!!	BigAddison	11/30/2014 9:27:22 AM

Newer

Recent Articles

• David Jeremiah Highlights Prayer's Impact on National Unity
• REC-4881 Shows Promising Results for FAP Treatment Amid Challenges
• Transforming the Maldives: A New Era for Financial Innovation
• Maldives Unveils Ambitious $8.8 Billion Financial Center Plan
• Potential Legal Action Regarding Avis Budget Group Securities
• Solo's Anniversary Celebration: Debt Payoff Giveaway & AI Innovation
• Top High Stim Pre-Workout Choices: Unleashing Your Gym Potential
• Ibotta, Inc. Faces Legal Challenges Amid IPO Controversy
• Important Update on Blue Cross Blue Shield Illinois Data Issues
• Alert: Personal Data Compromised in American Income Breach
• BigBear.ai Holdings Faces Legal Challenge from Investors
• Moonstruck Restaurant Changes Ownership: A New Chapter Ahead
• Investors Unite: Join the Fight Against Bakkt Holdings Fraud
• Bybit's Breakthrough Crypto Solutions Highlighted at Major Tech Event
• Top Muscle Building Supplements for Serious Lifters in 2024
• Investors Encouraged to Act in Actinium Pharmaceuticals Case
• Revolutionizing Fund Services: VENTURE.co's New Solutions
• Ministry of Hajj and Umrah Implements Strict Hajj Permit Rules
• Nutshell Therapeutics Secures FDA Clearance for NTS071 Trial
• Strategic Collaboration Between Binance and Kyrgyz Investments
• Sovereignty Triumphs in the Rain at the Kentucky Derby
• NFL Star Rondé Barber Honored with Doctorate at Commencement
• A Decade of Transformation in the Global Pet Products Market
• Canton Fair Spotlights Dynamic Changes in the Pet Industry
• Jane Seymour Inspires Graduates to Welcome Life's Changes
• How TransFi and Circle Are Changing Global Payments Dynamics
• La Roche-Posay Launches Free Skin Cancer Screenings Event
• Cerevel Therapeutics Lawsuit: A Chance for Shareholders to Act
• Unveiling Perpetua Resources Corp. Legal Developments for Investors
• Opportunities for Investors in Everus Construction Case
• Investors Can Join Fluence Energy, Inc. Class Action Now
• Investors Rally for Justice: Join Geron Corporation's Lawsuit
• Explore BexBack's Trading Opportunities Without KYC
• IBA Introduces Advanced QUASAR GRID3D for Image Analysis
• Ping An Offers Emergency Support for Citizens in U.S. Accident
• Exploring Sweet Innovations at the Canton Fair Food Expo
• Advocacy Efforts for Journalist Nika Novak by Press Freedom Center
• Discover the Best Mother's Day Gift: The Original 'Ove' Glove
• Join The Legal Fight: Bancorp Investors Seek Justice
• Zynex, Inc. Investors Encouraged to Join a Class Action Today
• Ping An Launches Emergency Aid for Chinese Citizens in U.S.
• Taiwan's Architectural Renaissance: The CMU Museum of Fine Arts
• Revolutionizing Racing: The Breakthrough 'Mountain Recharge' Project
• Celebrating the Best MBA Graduates: Class of 2025 Highlights
• Delightful Discoveries at the Canton Fair: Snacks Unleashed
• Innovations in Radiation Therapy Planning Unveiled by RaySearch
• Unilever's Advanced CLEAR Series Revolutionizes Scalp Care
• Understanding the NET Power Class Action Lawsuit: Key Details
• Viatris Investors Prompted for Action Amid Legal Developments
• Estee Lauder Under Scrutiny: Investigating Potential Misconduct